(GSUS) Goldman Sachs MarketBeta US - Ratings and Ratios
Large-Cap, Mid-Cap, U.S. Equity
Dividends
| Dividend Yield | 1.07% |
| Yield on Cost 5y | 2.10% |
| Yield CAGR 5y | 23.88% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 12.6% |
| Value at Risk 5%th | 21.7% |
| Relative Tail Risk | 5.02% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.62 |
| Alpha | 0.90 |
| CAGR/Max DD | 1.20 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.361 |
| Beta | 0.971 |
| Beta Downside | 0.983 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.07% |
| Mean DD | 2.19% |
| Median DD | 1.02% |
Description: GSUS Goldman Sachs MarketBeta US November 09, 2025
The Goldman Sachs MarketBeta US Equity ETF (GSUS) is a large-blend fund that tracks an index representing roughly the top 85 % of U.S. free-float market capitalization, focusing on large- and mid-cap stocks. By mandate, at least 80 % of its assets must be invested in the index’s constituent securities, including direct holdings and depositary receipts that mirror those equities.
Key metrics (as of the latest filing) show an expense ratio of 0.10 %, total assets of about $2.3 billion, and an annualized 12-month total return of ~11 %, closely mirroring the S&P 500’s performance. The fund’s sector exposure is weighted toward Information Technology (≈27 %), Health Care (≈14 %), and Consumer Discretionary (≈13 %), reflecting the composition of the broader U.S. equity market. Recent macro drivers-such as the Federal Reserve’s policy stance on interest rates and the ongoing labor market strength-have been primary determinants of the underlying index’s volatility.
For a deeper dive into GSUS’s risk-adjusted metrics and how it compares to peer ETFs, you might explore the analytical tools on ValueRay, which can help surface nuanced performance insights.
What is the price of GSUS shares?
Over the past week, the price has changed by +0.65%, over one month by -0.04%, over three months by +6.64% and over the past year by +15.16%.
Is GSUS a buy, sell or hold?
What are the forecasts/targets for the GSUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 112.4 | 18.5% |
GSUS Fundamental Data Overview December 02, 2025
Beta = 1.01
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.98b USD (2.98b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.98b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.98b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.59% (E(2.98b)/V(2.98b) * Re(9.59%) + (debt-free company))
Discount Rate = 9.59% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for GSUS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle